Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year 2025-09-23 12:00
Xinjiang celebrates seven decades of progress 2025-09-23 10:10
GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea 2025-09-23 09:41
Global Times: China's silver economy unleashes diversified opportunities, fueling growth of multiple sectors 2025-09-22 21:26
Global Times: China's silver economy: innovation, dignity, and shared opportunities 2025-09-22 21:20
Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine 2025-09-22 21:00
Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets 2025-09-22 21:00
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting 2025-09-22 20:00
Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer 2025-09-22 14:51
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy 2025-09-22 08:10
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends 2025-09-22 08:00
Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes 2025-09-19 18:01
DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting 2025-09-19 17:28
International Doctors Visit Smartee HQ and Share Insights on Next-Generation Orthodontics 2025-09-19 14:35
2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment 2025-09-19 09:39
QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025 2025-09-18 21:00
Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2) 2025-09-18 12:00
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway 2025-09-18 10:28
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025 2025-09-18 08:15
Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025 2025-09-18 07:30
1 16 17 18 19 20 889